The safety and efficacy of the microaxial SynFlow 3.0 flow pump system for patients undergoing high-risk percutaneous coronary intervention

Cardiology Plus · Published 2025-01-01 · DOI 10.1097/cp9.0000000000000115

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1097/cp9.0000000000000115

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Time-critical VA-ECMO-facilitated resuscitation and recovery after acute myocardial infarction with cardiogenic shock and cardiac arrest: a case report · Frontiers in Cardiovascular Medicine · 2026 · Cites or is cited by this article
• The role of myeloperoxidase as a biomarker in atherosclerotic cardiovascular disease · Cardiology Plus · 2024 · Same journal
• Single-cell sequencing and machine learning identify endoplasmic reticulum stress as a mechanism and therapeutic target in heart failure · Cardiology Plus · 2026 · Same journal
• Cardio-oncology training: a look under the hood · Cardiology Plus · 2025 · Same journal
• Histological validation of artificial intelligence–driven automatic plaque characterization in coronary OCT: a head-to-head comparison with clinicians · Cardiology Plus · 2025 · Same journal
• New insights into atherosclerotic cardiovascular disease through the lens of metabolism: expanding our approach · Cardiology Plus · 2025 · Same journal
• Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair · Cardiology Plus · 2025 · Same journal
• Cardiac light-chain amyloidosis: a clinical update · Cardiology Plus · 2026 · Same journal
• Cepharanthine aggravated atherosclerosis and liver injury in Apoe −/− and Ldlr −/− mice · Cardiology Plus · 2025 · Same journal
• Doxorubicin-induced cardiotoxicity: mechanisms, surveillance, and prevention strategies · Cardiology Plus · 2026 · Same journal